(Q47621371)

4 February 2018

title

A case-based evaluation of SRD5A1, SRD5A2, AR, and ADRA1A as candidate genes for severity of BPH. (English)

1 reference

4 February 2018

author

Katherine E. Hartmann

5

object named as

Hartmann KE

1 reference

4 February 2018

author name string

Klotsman M

1

1 reference

4 February 2018

Weinberg CR

2

1 reference

4 February 2018

Davis K

3

1 reference

4 February 2018

Binnie CG

4

1 reference

4 February 2018

publication date

1 January 2004

1 reference

4 February 2018

The Pharmacogenomics Journal

published in

1 reference

4 February 2018

volume

4

1 reference

4 February 2018

issue

4

1 reference

4 February 2018

page(s)

251-259

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500248

exact match

0 references

cites work

Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Androgen receptor: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Noradrenaline contractions of human prostate mediated by alpha 1A-(alpha 1c-) adrenoceptor subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

The autonomic and sensory innervation of the smooth muscle of the prostate gland: a review of pharmacological and histological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Characterization and chromosomal mapping of a human steroid 5 alpha-reductase gene and pseudogene and mapping of the mouse homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Alpha 1a-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Human adrenoceptor polymorphisms: evolving recognition of clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Androgen receptor CAG repeats and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5alpha-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Identification and selective inhibition of an isozyme of steroid 5 alpha-reductase in human scalp

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Benign prostatic hyperplasia: clinical overview and value of diagnostic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Molecular genetics of steroid 5 alpha-reductase 2 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Genes encoding adrenergic receptors are not clustered on the long arm of human chromosome 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

The concise handbook of family cancer syndromes. Mayo Familial Cancer Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

Case-Only Design to Measure Gene-Gene Interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

The development of human benign prostatic hyperplasia with age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

7 January 2021

Localization and expression of the alpha1A-1, alpha1B and alpha1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

7 January 2021

Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): correlation with adenoma growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

7 January 2021

Benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

7 January 2021

Overview of alpha-blocker therapy for benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

7 January 2021

Differences in steroid 5alpha-reductase iso-enzymes expression between normal and pathological human prostate tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

7 January 2021

Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

7 January 2021

CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

7 January 2021

Reproducibility and observer variability of transrectal ultrasound measurements of prostatic volume

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

7 January 2021

Detection of interaction involving identified genes: available study designs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500248

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500248

1 reference

4 February 2018

1 reference

4 February 2018